van der Velden, D., Lagraauw, H. M., Wezel, A., Launay, P., Kuiper, J., Huizinga, T. W. J., . . . Stoop, J. N. (2016). Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. Arthritis research & therapy, 18(1), 138. https://doi.org/10.1186/s13075-016-1036-8
Citace podle Chicago (17th ed.)van der Velden, Daniël, H. Maxime Lagraauw, Anouk Wezel, Pierre Launay, Johan Kuiper, Tom W. J. Huizinga, René E. M. Toes, Ilze Bot, a Jeroen N. Stoop. "Mast Cell Depletion in the Preclinical Phase of Collagen-induced Arthritis Reduces Clinical Outcome by Lowering the Inflammatory Cytokine Profile." Arthritis Research & Therapy 18, no. 1 (2016): 138. https://doi.org/10.1186/s13075-016-1036-8.
Citace podle MLA (9th ed.)van der Velden, Daniël, et al. "Mast Cell Depletion in the Preclinical Phase of Collagen-induced Arthritis Reduces Clinical Outcome by Lowering the Inflammatory Cytokine Profile." Arthritis Research & Therapy, vol. 18, no. 1, 2016, p. 138, https://doi.org/10.1186/s13075-016-1036-8.